Kreilein; Matthew Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kreilein; Matthew Michael.The latest application filed is for "compositions comprising an inhibitor of lysine specific demethylase-1".

Company Profile

2.14.14

Kreilein; Matthew Michael - Hillsborough NJ
Kreilein; Matthew Michael - Watchung NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions comprising an inhibitor of lysine specific demethylase-1 Grant 10,703,739 - Chen , et al.	2020-07-07
Processes for the preparation of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H- -purin-9-yl]-1-methylcyclohexane-1-carboxamide Grant 10,590,136 - Chen , et al.	2020-03-17
Compositions Comprising An Inhibitor Of Lysine Specific Demethylase-1 App 20190367473 - Chen; Young K. ; et al.	2019-12-05
Compositions comprising an inhibitor of lysine specific demethylase-1 Grant 10,316,016 - Chen , et al.	2019-06-11
Processes For The Preparation Of Cis-4-[2-{[(3s,4r)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9h- -purin-9-yl]-1-methylcyclohexane-1-carboxamide App 20190100522 - CHEN; Zheng ; et al.	2019-04-04
Compositions Comprising An Inhibitor Of Lysine Specific Demethylase-1 App 20180319767 - Chen; Young K. ; et al.	2018-11-08
Compositions comprising an inhibitor of lysine specific demethylase-1 Grant 10,047,069 - Chen , et al. August 14, 2	2018-08-14
Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-- 3,4-dihydropyrazino[2,3- B]pyrazin-2(1H)-one, a solid form there of and methods of their use Grant 9,974,786 - Beauchamps , et al. May 22, 2	2018-05-22
Pharmaceutical Compositions Of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-- 3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, A Solid Form Thereof And Methods Of Their Use App 20180071287 - BEAUCHAMPS; Marie Georges ; et al.	2018-03-15
PHARMACEUTICAL FORMULATIONS, PROCESSES, SOLID FORMS AND METHODS OF USE RELATING TO 1-ETHYL-7-(2-METHYL-6-(1H-1,2,4-TRIAZOL-3-YL)PYRIDIN-3-YL)-3,4-DIHYDROPYR- AZINO[2,3-b]PYRAZIN-2(1H)-ONE App 20180042924 - Menon; Anil ; et al.	2018-02-15
Compositions Comprising An Inhibitor Of Lysine Specific Demethylase-1 App 20180044320 - Chen; Young K. ; et al.	2018-02-15
Compositions comprising an inhibitor of lysine specific demethylase-1 Grant 9,828,358 - Chen , et al. November 28, 2	2017-11-28
Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyr- azino[2,3-b]pyrazin-2(1H)-one Grant 9,827,243 - Kreilein , et al. November 28, 2	2017-11-28
Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-- 3,4-dihydropyrazino [2,3-B]pyrazin-2(1H)-one, a solid form thereof and methods of their use Grant 9,795,603 - Beauchamps , et al. October 24, 2	2017-10-24
Pharmaceutical Compositions Of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-- 3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, A Solid Form Thereof And Methods Of Their Use App 20170182042 - BEAUCHAMPS; Marie Georges ; et al.	2017-06-29
Compositions Comprising An Inhibitor Of Lysine Specific Demethylase-1 App 20170129871 - Chen; Young K. ; et al.	2017-05-11
Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-YL)pyridin-3-YL)-1-((trans)-4-methoxycyclohexyl)-- 3,4-dihydropyrazino [2,3-B]pyrazin-2(1H)-one, a solid form thereof and methods of their use Grant 9,604,939 - Beauchamps , et al. March 28, 2	2017-03-28
PHARMACEUTICAL FORMULATIONS, PROCESSES, SOLID FORMS AND METHODS OF USE RELATING TO 1-ETHYL-7-(2-METHYL-6-(1H-1,2,4-TRIAZOL-3-YL)PYRIDIN-3-YL)-3,4-DIHYDROPYR- AZINO[2,3-b]PYRAZIN-2(1H)-ONE App 20160250210 - Menon; Anil ; et al.	2016-09-01
Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-- 3,4-dihydropyrazino [2,3-b]pyrazin-2(1H)-one, a solid form thereof and methods of their use Grant 9,403,829 - Connolly , et al. August 2, 2	2016-08-02
Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyr- azino[2,3-b] pyrazin-2(1H)-one Grant 9,359,364 - Menon , et al. June 7, 2	2016-06-07
Methods of synthesis and purification of heteroaryl compounds Grant 9,079,900 - Harris , et al. July 14, 2	2015-07-14
Pharmaceutical Compositions Of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-- 3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, A Solid Form Thereof And Methods Of Their Use App 20140356430 - BEAUCHAMPS; Marie Georges ; et al.	2014-12-04
PHARMACEUTICAL FORMULATIONS, PROCESSES, SOLID FORMS AND METHODS OF USE RELATING TO 1-ETHYL-7-(2-METHYL-6-(1H-1,2,4-TRIAZOL-3-YL)PYRIDIN-3-YL)-3,4-DIHYDROPYR- AZINO[2,3-b]PYRAZIN-2(1H)-ONE App 20140315908 - Menon; Anil ; et al.	2014-10-23
Methods Of Synthesis And Purification Of Heteroaryl Compounds App 20140155593 - Harris; Roy L. ; et al.	2014-06-05
Methods of synthesis and purification of heteroaryl compounds Grant 8,569,494 - Harris , et al. October 29, 2	2013-10-29
Methods Of Synthesis And Purification Of Heteroaryl Compounds App 20130245254 - Harris; Roy L. ; et al.	2013-09-19
Methods Of Synthesis And Purification Of Heteroaryl Compounds App 20110137028 - Harris; Roy L. ; et al.	2011-06-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.